Twin Tree Management
MDGL icon

Twin Tree Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Twin Tree Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-900
Closed -$278K – 1781
2024
Q4 		$278K Sell
900
-76,200
-99% -$21.4M ﹤0.01% 1376
2024
Q3 		$16.4M Sell
77,100
-12,800
-14% -$3.27M 0.03% 487
2024
Q2 		$25.2M Buy
89,900
+46,100
+105% +$11M 0.06% 310
2024
Q1 		$11.7M Buy
+43,800
New +$10.3M 0.03% 592
2023
Q3 		– Sell
-13,200
Closed -$3.05M – 1401
2023
Q2 		$3.05M Sell
13,200
-19,000
-59% -$5.15M ﹤0.01% 864
2023
Q1 		$7.8M Buy
+32,200
New +$8.77M 0.01% 631

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Twin Tree Management's MDGL Position: Q3 2025 in Review

Twin Tree Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2025, closing a stake of 336 shares — an estimated $102K sold.

Twin Tree Management first reported a position in MDGL in Q1 2019 and held it in 7 quarters. The position peaked at $8.09M in Q1 2024. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • Twin Tree Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Twin Tree Management sold 336 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $102K.
  • Twin Tree Management first reported a position in Madrigal Pharmaceuticals in Q1 2019 and held it in 7 quarters.
  • Twin Tree Management's Madrigal Pharmaceuticals position peaked at $8.09M in Q1 2024.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on Twin Tree Management's 13F filing for Q3 2025, filed 13 Nov 2025.